Beta-glucan- or rice bran-enriched foods: A comparative crossover clinical trial on lipidic pattern in mildly hypercholesterolemic men

European Journal of Clinical Nutrition

Volumn 65, Issue 7, 2011, Pages 864-871

  Rondanelli, M ^a   Opizzi, A ^a   Monteferrario, F ^a   Klersy, C ^b   Cazzola, R ^c   Cestaro, B ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

barley; beta glucan; dietary fiber; rice bran; serum cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA GLUCAN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DISEASE SEVERITY; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MALE; QUALITY OF LIFE; RICE BRAN; TRIACYLGLYCEROL BLOOD LEVEL;

HORDEUM;

EID: 85027935454     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.48     Document Type: Article

References (31)

1. Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD (1996). A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 39, 681-685. (Pubitemid 26181138)
2. American Heart Association (1988). Dietary guidelines for healthy American adults. A statement for physicians and health professional by the Nutrition Committee. Circulation 77, 721A-724A.
3. Anderson JW (1987). Dietary fiber, lipids and atherosclerosis. Am J Cardiol 60, 17G-22G. (Pubitemid 17164561)
4. Avellone G, Di Garbo V, Cordova R, Panno AV, Verga S, Bompiani G (1997). Food habits and cardiovascular risk factors in 2 population samples of western Sicily. Ann Ital Med Int 12: 210-216.
5. Behall KM, Scholfield DJ, Hallfrisch J (2004). Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr 80, 1185-1193. (Pubitemid 41350677)
6. Brown L, Rosner B, Willett WW, Sacks FM (1999). Cholesterollowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42. (Pubitemid 29031248)
7. Burkitt DP, Walker AR, Painter NS (1974). Dietary fiber and disease. JAMA 229, 1068-1074.
8. Cheng HH, Huang HY, Chen YY, Huang CL, Chang CJ, Chen HL et al. (2010). Ameliorative effects of stabilized rice bran on type 2 diabetes patients. Ann Nutr Metab 56, 45-51.
9. Drozdowski LA, Reimer RA, Temelli F, Bell RC, Vasanthan T, Thomson AB (2010). Beta-glucan extracts inhibit the in vitro intestinal uptake of long-chain fatty acids and cholesterol and down-regulate genes involved in lipogenesis and lipid transport in rats. J Nutr Biochem 21, 695-701.
10. Food and Drug Administration (2005). Food Labeling: Health Claims; Soluble Dietary Fiber From Certain Foods and Coronary Heart Disease; Final Rule. US Department of Health and Human Services: Rockville, MD. Available at http://vm.cfsan.fda.gov/-lrd/fr970123.html.
11. Frisancho AR (1984). New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly. Am J Clin Nutr 40, 808-819. (Pubitemid 14014416)
12. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB et al. (2004). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239. (Pubitemid 38924592)
13. Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, Faulkner D et al. (2002). Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 75, 834-839. (Pubitemid 34441251)
14. Keogh GF, Cooper GJ, Mulvey TB, McArdle BH, Coles GD, Monro JA et al. (2003). Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 78, 711-718. (Pubitemid 39663488)
15. Keys A, Anderson JT, Grande F (1960). Diet-type (fats constant) and blood lipids in man. J Nutr 70, 257-266.
16. Kirby RW, Anderson JW, Sieling B, Rees ED, Chen WJ, Miller RE et al. (1981). Oat-bran intake selectively lowers serum low-density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 35, 824-829. (Pubitemid 11077914)
17. Kostapanos MS, Milionis HJ, Elisaf MS (2010). Rosuvastatinassociated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 10, 11-28.
18. Kottke TE, Puska P, Salonen JT, Tuomilehto J, Nissinen A (1985). Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol 121, 697-704. (Pubitemid 15056504)
19. Lia A, Hallmans G, Sandberg AS, Sundberg B, Aman P, Andersson H (1995). Oat beta-glucan increases bile acid excretion and a fiberrich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 62, 1245-1251.
20. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA (1994). Mechanism of serum cholesterol reduction by oat bran. Hepatology 20, 1450-1457. (Pubitemid 24359055)
21. McIntosh GH, Whyte J, McArthur R, Nestel PJ (1991). Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. Am J Clin Nutr 53, 1205-1209.
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421.
23. Qureshi AA, Mo H, Packer L, Peterson DM (2000). Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J Agric Food Chem 48, 3130-3140.
24. Reihner E, Angelin B, Rudling M, Ewerth S, Bjorkhem I, Einarsson K (1990). Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res 31, 2219-2226.
25. Rivellese AA, Boemi M, Cavalot F, Castigliola L, De Feo P, Miccoli R et al. (2008). Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations? Eur J Clin Nutr 62, 660-664. (Pubitemid 351663406)
26. Shimizu C, Kihara M, Aoe S, Araki S, Ito K, Hayaski K et al. (2008). Effect of high b-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men-a randomized, doubleblinded, placebo-controlled trial. Plants Foods Hum Nutr 63, 21-25.
27. Sugano M, Koba K, Tsuji E (1999). Health benefits of rice bran oil. Anticancer Res 19, 3651-3657.
28. Talati R, Baker WL, PabiloniaMS, White CM, Coleman CI (2009). The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med 7, 157-163.
29. Trowell HC (1975). Dietary-fiber hypothesis of the etiology of diabetes mellitus. Diabetes 24, 762-765.
30. Ware JE, Snow KK, Kosinski M, Gandek B (1993). SF-36 Health Survey: Manual and Interpretation Guide. The Health Institute: Boston, MA.
31. Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D (2007). Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 18, 105-112. (Pubitemid 46048986)